Tuesday, 17 October 2017

CMA confirms more investigations in pharma

The Competition and Markets Authority has announced that it is conducting three further investigations into suspected anticompetitive arrangements in the pharmaceutical sector.  The statement confirms the CMA’s already extensive probes in the sector.
The three investigations will all examine possible collusion, while two will also investigate abuse of dominance.
Aspen Pharma has confirmed that a new CMA investigation will focus on the supply of steroids used primarily to treat Addison’s disease, and another product used to treat a range of inflammatory diseases including asthma, allergies, arthritis, blood disorders and kidney disease.
Concordia has confirmed that the CMA is investigating some products in its “international segment”.

The CMA has also extended a separate investigation into Concordia, launched on 25 October 2016, for alleged excessive pricing of drugs supplied to the NHS. 

1 comment:

  1. Hi Suzanne,

    My name is Anuj Agarwal. I'm Founder of Feedspot.

    I would like to personally congratulate you as your blog Competition Intelligence has been selected by our panelist as one of the Top 75 Business Law Blogs on the web.

    https://blog.feedspot.com/business_law_blogs/

    I personally give you a high-five and want to thank you for your contribution to this world. This is the most comprehensive list of Top 75 Business Law Blogs on the internet and I’m honored to have you as part of this!

    Also, you have the honor of displaying the badge on your blog.

    Best,
    Anuj

    ReplyDelete